Literature DB >> 15564841

Familial non-medullary thyroid cancer: a matched-case control study.

Evelyn Linda Maxwell1, Francis T Hall, Jeremy L Freeman.   

Abstract

OBJECTIVES: Familial non-medullary thyroid cancer (FNMTC) is a newly recognized disease entity and can be distinguished from the more common sporadic non-medullary thyroid cancer. The purpose of this study was to determine some of the potential distinguishing features of FNMTC. STUDY
DESIGN: Retrospective association study and matched-case control study.
METHODS: Five hundred forty-three cases of well-differentiated follicular origin thyroid cancers were identified and collected in a database. Among this population, 24 cases of FNMTC were identified. A case of FNMTC was defined as a patient with the following two criteria: a well-differentiated follicular origin thyroid cancer and at least one first-degree relative with a well-differentiated epithelial origin thyroid cancer. The unmatched sporadic and FNMTC groups were compared using t test, Phi test, Cramer V test, and Pearson and Spearman correlation tests. Twenty-four FNMTC cases were matched to 24 sporadic cases based on age, gender, stage of disease at presentation, and tumor size. Clinicopathologic features, management, and outcome were analyzed statistically using a matched-proportional z test. Disease-free survival and disease-specific survival were analyzed using log-rank test and the Kaplan-Meier function. A P-value less than .05 was considered statistically significant.
RESULTS: : There was no significant difference in ionizing radiation exposure, disease multifocality, surgical management, or recurrence between the sporadic and FNMTC patients. Although FNMTC patients tend to have improved disease-free survival and disease-specific survival, the difference was not significant at the 5% level.
CONCLUSION: Although FNMTC is characterized by strong family history, these patients do not tend to have worse prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15564841     DOI: 10.1097/01.mlg.0000149454.91005.65

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  22 in total

1.  The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Authors:  Young Joo Park; Hwa Young Ahn; Hoon Sung Choi; Kyung Won Kim; Do Joon Park; Bo Youn Cho
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

2.  Does familial non-medullary thyroid cancer adversely affect survival?

Authors:  Frederic Triponez; Mariwil Wong; Cord Sturgeon; Nadine Caron; David G Ginzinger; Mark R Segal; Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 3.  Controversies in familial thyroid cancer 2014.

Authors:  Orlo H Clark
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

Review 4.  An update on familial nonmedullary thyroid cancer.

Authors:  Sabrine A Ammar; Wilson M Alobuia; Electron Kebebew
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

5.  Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.

Authors:  Andreas Hillenbrand; Jan-Erik Varhaug; Michael Brauckhoff; Rumen Pandev; Sabine Haufe; Cornelia Dotzenrath; Roswitha Köberle; Rainer Hoffmann; Günther Klein; Martina Kadmon; Thomas Negele; Tatjana Hagieva; Doris Henne-Bruns; Markus Luster; Theresia Weber
Journal:  Langenbecks Arch Surg       Date:  2010-08-05       Impact factor: 3.445

6.  Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.

Authors:  Tae-Yon Sung; Yu-mi Lee; Jong Ho Yoon; Ki-Wook Chung; Suck Joon Hong
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

7.  RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study.

Authors:  Matteo Landriscina; Maria Iole Natalicchio; Olga Lamacchia; Antonella Conserva; Annamaria Piscazzi; Anna Ciampolillo; Matteo Zingrillo; Antonio Pennella; Pantaleo Bufo; Giulia Vita; Raffaele Antonetti; Eugenio Maiorano; Francesco Giorgino; Mauro Cignarelli
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

8.  Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.

Authors:  Willieford Moses; Julie Weng; Electron Kebebew
Journal:  Thyroid       Date:  2010-12-29       Impact factor: 6.568

9.  Results of Screening in Familial Non-Medullary Thyroid Cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Lily Yang; Roxanne Merkel; Dhaval Patel; Naris Nilubol; Maria J Merino; Monica Skarulis; Samira M Sadowski; Electron Kebebew
Journal:  Thyroid       Date:  2017-07-19       Impact factor: 6.568

Review 10.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.